TrialAnnals of surgery2018

A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.

Henry M Kuerer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.